Overview
Obligated since award on contracts active FY2021–FY2026
Click a company to open its profile.
Insight NATIONAL INSTITUTES OF HEALTH - CC (75N900) is its largest buyer. See more on the Buyers tab
Agencies report with a delay; the latest year will rise
Hover over a year to see its value.
Insight Largest year: $405K in FY2024. See more on the Contracts tab
$1.4M since award = $1.06M in FY2021–FY2026 + $337K before FY2021
Click a state to open its page.
Insight 96% was performed in Texas. See more on the Contracts tab
Contracts
13 contracts with an action since FY2021
Click a tile to open its contract.
Insight Stand-alone contracts hold 59% of these contracts' obligations.
In FY2025, its other prime contracts net below zero after deobligations, so 75N90019D00030 orders exceed all prime contracts
Hover over a year to see its value.
Insight 33% of its prime obligations came through 75N90019D00030 orders.
Current end date of each prime contract with an action since FY2021
Hover over a month to see its value.
Quva Pharma, Inc. prime contracts with an action in FY2021–FY2026
Find a contract by vehicle, office or end date; sort by money to see the largest.
1 end within 12 months.
Showing 1–10 of 13 contracts
| Since award, US$ | |||||
|---|---|---|---|---|---|
| Parent contract (IDVIDV: the record type for any contract that exists to take orders: IDIQs, GWACs, GSA Schedules, BPAs and basic ordering agreements. Glossary) | ObligatedObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary | ||||
| W81K0019P0334 | Stand-alone | W40M MRC0 WEST (W81K00) | $442,635 | Sep 30, 2024 | Ended |
| 75N90024F00001 | 75N90019D00030 | NATIONAL INSTITUTES OF HEALTH - CC (75N900) | $250,000 | Sep 30, 2024 | Ended |
| 75N90020F00002 | 75N90019D00030 | NATIONAL INSTITUTES OF HEALTH - CC (75N900) | $174,000 | Mar 31, 2022 | Ended |
| 75N98026P00592 | Stand-alone | NATIONAL INSTITUTES OF HEALTH OLAO (75N980) | $110,000 | May 25, 2027 | Ends within 12 months |
| 75N90025P00194 | Stand-alone | NATIONAL INSTITUTES OF HEALTH - CC (75N900) | $100,000 | Feb 18, 2026 | Ended |
| 75N90022F00001 | 75N90019D00030 | NATIONAL INSTITUTES OF HEALTH - CC (75N900) | $100,000 | Sep 25, 2022 | Ended |
| 75N90023P00020 | Stand-alone | NATIONAL INSTITUTES OF HEALTH - CC (75N900) | $60,000 | Oct 23, 2023 | Ended |
| 36C26120P0486 | Stand-alone | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $51,530 | Sep 30, 2020 | Ended |
| 75N90020F00001 | 75N90019D00030 | NATIONAL INSTITUTES OF HEALTH - CC (75N900) | $45,670 | Oct 31, 2020 | Ended |
| W81K0019P0271 | Stand-alone | W40M MRC0 WEST (W81K00) | $32,124 | Sep 30, 2021 | Ended |
Buyers
National Institutes of Health: $869K obligated since award; $696K in FY2021–FY2025 actions
Click a tile to open its office page.
Insight National Institutes of Health placed 62%.
Contracting offices that awarded Quva Pharma, Inc. prime contracts, FY2021–FY2026
See which offices award its contracts.
2 offices awarded only one contract.
Showing 1–4 of 4 offices
| Contracts active FY2021–FY2026; obligated since award, US$ | |||||
|---|---|---|---|---|---|
| NATIONAL INSTITUTES OF HEALTH - CC (75N900) | National Institutes of Health | 8 | $759,199 | Sep 27, 2019 | Apr 30, 2026 |
| W40M MRC0 WEST (W81K00) | Department of the Army | 3 | $474,759 | Dec 7, 2017 | Apr 21, 2025 |
| NATIONAL INSTITUTES OF HEALTH OLAO (75N980) | National Institutes of Health | 1 | $110,000 | May 26, 2026 | May 29, 2026 |
| 261-NETWORK CONTRACT OFFICE 21 (36C261) | Department of Veterans Affairs | 1 | $51,530 | Feb 18, 2020 | Jun 14, 2021 |
Opportunities
Open opportunities matching Quva Pharma, Inc.'s registered industries
Notices in its 1 industry (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary): 325412
8 of the next 10 are due within 30 days.
Showing 1–10 of 10 opportunities
| Opportunity | Agency | Due |
|---|---|---|
| Notice of Intent to Sole Source – CARDINAL HEALTH 414, LLC– radiopharmaceuticals (opens in Procura)Presolicitation · NAICS 325412Free account: full notice, dates, attachments | National Institutes of Health (HHS)NATIONAL INSTITUTES OF HEALTH OLAO (75N980) | Oct 19, 2026 |
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America (opens in Procura)Presolicitation · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNAC PHARMACEUTICALS (36E797) | Oct 21, 2026 |
| Inhaled Nitric Oxide (opens in Procura)Sources Sought · NAICS 325412Free account: full notice, dates, attachments | Defense Health Agency (DOD)DEFENSE HEALTH AGENCY (HT9408) | Oct 22, 2026 |
| Methylphenidate ER (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Defense Logistics Agency (DOD)DLA TROOP SUPPORT (SPE2D2) | Oct 23, 2026 |
| Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Defense Health Agency (DOD)DEFENSE HEALTH AGENCY (DHA) (HT0040) | Oct 26, 2026 |
| 6505--Imatinib Tablets (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNAC PHARMACEUTICALS (36E797) | Oct 30, 2026 |
| LIDOCAINE 5% PATCHES-REQUEST FOR INFORMATION (opens in Procura)Sources Sought · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNATIONAL CMOP OFFICE (36C770) | Nov 3, 2026 |
| Epinephrine Injector (opens in Procura)Solicitation · NAICS 325412Free account: full notice, dates, attachments | Defense Logistics Agency (DOD)DLA TROOP SUPPORT (SPE2D2) | Nov 16, 2026 |
| 6505--Department of Veterans Affairs Pharmaceutical Industry Day (opens in Procura)Special Notice · NAICS 325412Free account: full notice, dates, attachments | Department of Veterans AffairsNAC FEDERAL SUPPLY SCHEDULE (36F797) | Nov 20, 2026 |
| TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform (opens in Procura)Special Notice · NAICS 325412Free account: full notice, dates, attachments | Department of EnergyOffice 899015 | Dec 4, 2026 |
Registration and contacts
Registration
- UEI
- MUABDCZXMLG4
- CAGE code
- 7VLA4
- Registration
- Active, expires Nov 4, 2026
- Entity type
- Corporate Entity (Not Tax Exempt)
- Location
- SUGAR LAND, TX, 77478
- Congressional district
- TX-22
Registered industries (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary)
Registered in 1 industry; primary 325412
- 325412 Pharmaceutical Preparation ManufacturingPrimary
Contacts at Quva Pharma, Inc.
| Contact | Role | As of |
|---|---|---|
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Company contactSBA profileAs of Oct 4, 2026 | Oct 4, 2026 |
Correct this listing
Tell us what to correct or add on the Quva Pharma, Inc. page. We check every request before we change a profile.